All In Biotech

Drug Trial Radar · NCT03390010

Misoprostol Versus Active Management of Labour in CS

Intrauterine Misoprostol With Active Management of Labour Versus Active Management of Labour for Prevebtion of Postpartum Hemorage in Cesarean Section ,Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Nov 16, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

300

Actual

Start

Dec 28, 2017

Primary completion

Feb 28, 2018

Study completion Mar 6, 2018

Sponsor

Lead sponsor
Aljazeera HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Cairo University
First posted
Jan 4, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 42 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Several treatment strategies are emplemented to prevent post delivery hemorage and decreasing maternal morbidity and mortality .

Conditions

  • Cesarean Section

Interventions

  • Misoprostol + syntocinon and using extra uterotonic drugs when needed ; methergineDrug

    medical prophylaxis against postpartum atony and postpartum hemorage by giving misoprostol plus syntocinon and using extra uterotonic drugs when needed ; methergine, carboprost

  • Syntocinon and using extra uterotonic drugs when needed ; methergine carboprostDrug

    medical prophylaxis against postpartum atony and postpartum hemorage by giving syntocinon and using extra uterotonic drugs when needed ; methergine, carboprost

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The number of participants who passed cesarean section without postpartum hemorageTime frame: within 2 days post CS

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Algazeerah

    Giza, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.